M. A. Sendur Et Al. , "EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER," 39th ESMO Congress (ESMO) , vol.25, Madrid, Spain, 2014
Sendur, M. A. Et Al. 2014. EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER. 39th ESMO Congress (ESMO) , (Madrid, Spain).
Sendur, M. A., Aksoy, S., Uncu, D., Demir, H., Yuksel, S., Ekinci, A. S., ... Kaplan, A.(2014). EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER . 39th ESMO Congress (ESMO), Madrid, Spain
Sendur, M. Et Al. "EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER," 39th ESMO Congress (ESMO), Madrid, Spain, 2014
Sendur, M. A. Et Al. "EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER." 39th ESMO Congress (ESMO) , Madrid, Spain, 2014
Sendur, M. A. Et Al. (2014) . "EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER." 39th ESMO Congress (ESMO) , Madrid, Spain.
@conferencepaper{conferencepaper, author={M. A. Sendur Et Al. }, title={EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER}, congress name={39th ESMO Congress (ESMO)}, city={Madrid}, country={Spain}, year={2014}}